Tirzepatide

Description

Reference standard for GLP-1/GIP dual-agonist research. one of the most widely studied incretin compounds.

Mechanism

Dual agonist of GLP-1 and GIP receptors. modulates glycemic control and adipose signaling.

Research applications

• Metabolic research
• Adipose biology
• Glucose homeostasis

Specifications

• Purity: 99.7% (HPLC / MS verified)
• Vial size: 5mg
• Available sizes: 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 60mg
• Form: Lyophilized powder
• Storage: -20°C, protect from light

For laboratory research use only. Not for human or veterinary use. Lot-matched Certificate of Analysis included with every order.